![](/img/cover-not-exists.png)
13509 Integrated safety analysis of FMX103 1.5% topical minocycline foam for the treatment of moderate to severe papulopustular rosacea: Results from two phase 3 studies
Gold, Linda Stein, Del Rosso, James Q., Kircik, Leon, Bhatia, Neal, Hooper, Deirdre, Nahm, Walter K.Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.566
Date:
December, 2020
File:
PDF, 1.45 MB
2020